Travaux scientifiques
Doç. Dr. Nargız Majıdova
92 publications. La source de l’information est indiquée à côté de chaque publication.
-
Management of hepatotoxicity associated with CDK4/6 inhibitors and rechallenge strategies in metastatic hormone-positive, HER2-negative breast cancer
Journal of Cancer Research and Clinical Oncology, 2025
DOI 10.1007/s00432-025-06336-1 PMID 41014426 4 citations (Europe PMC) Texte intégral en libre accèsSource : ORCID
-
Clinical and Demographic Features in Malignant Peritoneal Mesothelioma: Treatment Approaches and Factors Affecting Survival
Journal of Oncological Sciences, 2025
DOI 10.37047/jos.galenos.2025.2025-3-18 Texte intégral en libre accèsSource : OpenAlex
-
2184P Abscopal effect in patients with metastatic non-small cell lung cancer treated with nivolumab: A multicenter study
Annals of Oncology, 2025
DOI 10.1016/j.annonc.2025.08.2803 Texte intégral en libre accèsSource : OpenAlex
-
2836P The effect of ribociclib dose reduction on progression-free survival in hormone receptor positive and HER-2 negative metastatic breast cancer: A multicenter study
Annals of Oncology, 2025
DOI 10.1016/j.annonc.2025.08.3448 Texte intégral en libre accèsSource : OpenAlex
-
Efficacy and Safety of the Topotecan–Cyclophosphamide Regimen in Adult Metastatic Ewing Sarcoma: A Large, Multicenter, Real-World Study
Cancers, 2025
DOI 10.3390/cancers17030550 PMID 39941915 1 citation (OpenAlex) Texte intégral en libre accèsSource : OpenAlex
-
Clinicopathological features and treatment outcomes of patients with fibrolamellar hepatocellular carcinoma: a retrospective multicenter study
Annals of Saudi Medicine, 2025
DOI 10.5144/0256-4947.2025.249 PMID 40753462 1 citation (OpenAlex) Texte intégral en libre accèsSource : OpenAlex
-
Impact of Sarcopenia and Osteopenia on Prognosis in Metastatic Biliary Tract Cancer: A Single Center Experience
Nutrition and Cancer, 2025
DOI 10.1080/01635581.2025.2496371 PMID 40327413 1 citation (OpenAlex) Source : OpenAlex
-
Colorectal Cancer Metastasizing to the Thyroid Gland: A Rare and Interesting Case
Journal of Oncological Sciences, 2025
DOI 10.37047/jos.galenos.2025.2025-3-11 Texte intégral en libre accèsSource : OpenAlex
-
Impact of renin angiotensin system inhibitors on survival of patients with metastatic non-small cell lung cancer.
PubMed Central, 2025
DOI 10.5144/0256-4947.2025.18 PMID 39929787 6 citations (OpenAlex) Texte intégral en libre accèsSource : OpenAlex
-
Sex-related disparities in outcomes of survival in biliary tract cancer patients
Journal of Cancer Research and Clinical Oncology, 2025
DOI 10.1007/s00432-025-06096-y PMID 40016575 1 citation (OpenAlex) Texte intégral en libre accèsSource : OpenAlex
-
Denovo Metastatic Primary Gastric Ewing Sarcoma/Primitive Neuroectodermal Tumor– 13 Years Follow-up: Case Report and Review of Literature
Journal of Medicine and Medical Studies, 2025
DOI 10.51219/jmms/guren-ak/19 Texte intégral en libre accèsSource : OpenAlex
-
Efficacy of adjuvant capecitabine in residual triple negative breast cancer: a multicenter observational Turkish Oncology Group (TOG) study
Expert Opinion on Pharmacotherapy, 2024
DOI 10.1080/14656566.2024.2337261 PMID 38568074 1 citation (Europe PMC) Texte intégral en libre accèsSource : OpenAlex
-
Kanser Hastalarının Başvurduğu Geleneksel ve Tamamlayıcı Tedaviler - Tıbbi Onkolog Gözü ile Bakış ve Onkolojik İlaçlarla Etkileşim
Akademisyen Kitabevi eBooks, 2024
DOI 10.37609/akya.2380 Texte intégral en libre accèsSource : OpenAlex
-
Efficacy and Safety of Ixabepilone in Metastatic Breast Cancer After Multiple Treatments: Analysis Based on Real-World Data
Journal of Oncological Sciences, 2024
DOI 10.37047/jos.2024-102164 1 citation (OpenAlex) Texte intégral en libre accèsSource : OpenAlex
-
The prognostic factors in patients with advanced hepatocellular carcinoma: impact of treatment sequencing
Journal of Chemotherapy, 2024
DOI 10.1080/1120009x.2024.2305066 PMID 38263804 2 citations (Europe PMC) Source : OpenAlex
-
Efficacy of first-line CDK 4-6 inhibitors in premenopausal patients with metastatic breast cancer and the effect of dose reduction due to treatment-related neutropenia on efficacy: a Turkish Oncology Group (TOG) study
Journal of Chemotherapy, 2024
DOI 10.1080/1120009x.2024.2330835 PMID 38497444 7 citations (Europe PMC) Texte intégral en libre accèsSource : OpenAlex
-
Total Neoadjuvant Therapy Versus Neoadjuvant Chemoradiation for Locally Advanced Rectal Cancer: A Multi-Institutional Real-World Study
Cancers, 2024
DOI 10.3390/cancers16183213 PMID 39335184 8 citations (Europe PMC) Texte intégral en libre accèsSource : OpenAlex
-
Comparison of the efficacy of sunitinib and pazopanib in patients with advanced non-clear renal cell carcinoma
Journal of Chemotherapy, 2024
DOI 10.1080/1120009x.2024.2403051 PMID 39257075 2 citations (Europe PMC) Source : OpenAlex
-
The effects of low HER2 expression on survival in patients with metastatic breast cancer treated with CDK 4/6 inhibitors: a multicenter retrospective study
Breast Cancer Research and Treatment, 2024
DOI 10.1007/s10549-024-07291-0 PMID 38526689 6 citations (Europe PMC) Texte intégral en libre accèsSource : OpenAlex
-
Real-world evaluation of nivolumab in patients with non-nasopharyngeal recurrent or metastatic head and neck cancer: a retrospective multi-center study by the Turkish Oncology Group (TOG)
European Archives of Oto-Rhino-Laryngology, 2024
DOI 10.1007/s00405-024-08744-4 PMID 38795147 5 citations (Europe PMC) Texte intégral en libre accèsSource : OpenAlex
-
Clinicopathologic Features and Efficacy of Induction Chemotherapy in Nasopharyngeal Carcinoma: Real-World Experience
Oncology Research and Treatment, 2024
DOI 10.1159/000537988 PMID 38565096 2 citations (Europe PMC) Texte intégral en libre accèsSource : ORCID
-
Bevacizumab versus aflibercept with FOLFIRI after FOLFOX and bevacizumab in RAS mutant metastatic colon cancer a Turkish oncology group study
Scientific Reports, 2024
DOI 10.1038/s41598-024-81371-5 PMID 39616250 2 citations (Europe PMC) Texte intégral en libre accèsSource : ORCID
-
Prognostic value of systemic inflammatory markers in renal cell carcinoma with isolated lung metastases: A retrospective analysis
Turkish Journal of Clinics and Laboratory, 2024
DOI 10.18663/tjcl.1531223 Texte intégral en libre accèsSource : ORCID
-
Regorafenib Treatment for Recurrent Glioblastoma Beyond Bevacizumab-Based Therapy: A Large, Multicenter, Real-Life Study
Cancers, 2024
DOI 10.3390/cancers17010046 PMID 39796675 9 citations (Europe PMC) Texte intégral en libre accèsSource : ORCID
-
Which factors help to determine the long-term response to first-line tyrosine kinase inhibitors in patients with metastatic renal cell carcinoma: A Turkish multi-centre study
Biomolecules and Biomedicine, 2024
DOI 10.17305/bb.2024.10512 PMID 38920621 1 citation (Europe PMC) Texte intégral en libre accèsSource : ORCID
-
Evaluation of sarcopenia-associated survival in breast cancer with computed tomography-based pectoral muscle area measurements
Marmara Medical Journal, 2024
DOI 10.5472/marumj.1484705 1 citation (OpenAlex) Texte intégral en libre accèsSource : ORCID
-
Balık Yağı / Omega Yağları
Akademisyen Kitabevi eBooks, 2024
DOI 10.37609/akya.2380.c13930 Source : ORCID
-
An evaluation of the clinical and treatment features of renal cell carcinoma
Journal of Experimental and Clinical Medicine (Turkey), 2024
DOI 10.52142/omujecm.41.2.12 Source : ORCID
-
Efficacy of Gemcitabine Plus Nab-paclitaxel in Second-line Treatment of Metastatic Pancreatic Cancer: a Multicenter Retrospective Study in Turkey
Research Square, 2024
DOI 10.21203/rs.3.rs-4800776/v1 Texte intégral en libre accèsSource : ORCID
-
Efficacy of cumulative cisplatin dose on survival in patients with locally advanced cervical cancer treated with definitive chemoradiotherapy: multicenter study by Turkish Oncology Group
International Journal of Gynecological Cancer, 2024
DOI 10.1136/ijgc-2024-005419 PMID 38950923 5 citations (Europe PMC) Texte intégral en libre accèsSource : ORCID
-
HER2 exon 20 mutant non-small cell lung cancer with complete remission of intracranial metastases with trastuzumab deruxtecan: A case report
Anti-Cancer Drugs, 2024
DOI 10.1097/cad.0000000000001625 PMID 39115060 4 citations (Europe PMC) Source : ORCID
-
Systemic Inflammation Response Index and Pan-Immune-Inflammation Value: Prognostic Significance in Metastatic Melanoma
Journal of Oncological Science, 2024
DOI 10.37047/jos.2024-105164 Texte intégral en libre accèsSource : ORCID
-
Gustave Roussy Immune Score (GRIm-Score) Predicts Prognosis in Non-Small Cell Lung Cancer Patients Undergoing Nivolumab: A Multicenter Retrospective Study from Turkiye
International Journal of Hematology and Oncology, 2024
DOI 10.4999/uhod.247871 Texte intégral en libre accèsSource : OpenAlex
-
PNI as a Potential Add-On Biomarker to Improve the IMDC Intermediate Prognostic Score
Journal of Clinical Medicine, 2023
DOI 10.3390/jcm12196420 PMID 37835062 3 citations (Europe PMC) Texte intégral en libre accèsSource : OpenAlex
-
Prognostic Significance of Mucinous Histology in Metastatic Colorectal Cancer Patients Treated with Regorafenib
Journal of Oncological Science, 2023
DOI 10.37047/jos.2022-94250 Texte intégral en libre accèsSource : ORCID
-
The effects of low HER2 expression on survival in patients with metastatic breast cancer treated with CDK 4/6 inhibitors: A multicentre retrospective study
Research Square, 2023
DOI 10.21203/rs.3.rs-3752382/v1 Texte intégral en libre accèsSource : ORCID
-
The prognostic importance of clinicopathological factors in patients with osteosarcoma who received neoadjuvant therapy; a single center experience
Research Square, 2023
DOI 10.21203/rs.3.rs-3610643/v1 Texte intégral en libre accèsSource : ORCID
-
Evaluation of Predictive and Prognostic Importance of Lung Immune Prognostic Index in Locally Advanced Rectal Cancer Patients Treated With Neoadjuvant Chemoradiotherapy
Cureus, 2023
DOI 10.7759/cureus.40548 PMID 37465788 3 citations (Europe PMC) Texte intégral en libre accèsSource : ORCID
-
Impact of Skeletal Muscle Measurements by Chest Computed Tomography on Survival and Postoperative Complications in Patients with Soft Tissue Sarcoma
Nutrition and Cancer, 2022
DOI 10.1080/01635581.2022.2063349 PMID 35416100 3 citations (Europe PMC) Texte intégral en libre accèsSource : ORCID
-
Is diabetes onset at advanced age a sign of pancreatic cancer?
Annali Italiani di Chirurgia, 2022
PMID 36156490 1 citation (OpenAlex) Source : ORCID
-
Bilateral testicular metastasis of prostate adenocarcinoma: A case report
Journal of Experimental and Clinical Medicine (Turkey), 2019
DOI 10.5835/jecm.omu.36.02.006 Texte intégral en libre accèsSource : ORCID
-
Aggressive skin metastasis in lung cancer,Akciğer kanserinde nadir görülen yaygın cilt metastazı
Tuberkuloz ve Toraks, 2018
DOI 10.5578/tt.67010 PMID 30479233 Source : ORCID